Approach
Each CORAL member works on human study collections from the general population, clinical trials or patients and is focused on neurological diseases such as Alzheimer’s disease, Lewy bodies dementia, Parkinson’s disease, Frontotemporal Dementia (FTD), Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Amyotrophic lateral sclerosis (ALS) and epilepsy. Together, members can validate their findings and identify leads for cross-disease markers and mechanisms.
The goals:
- Sharing experiences with biomarker development workflows, starting from cerebrospinal fluid (CSF) and plasma proteins on the Olink Proteomics platform.
- Performing collaborative meta-analyses and other studies to identify novel mechanisms and biomarkers for neurological diseases.
New members are welcomed, particularly groups that have already published or are working on their Olink proteomics dataset and are seeking to share experiences and collaborate with others.
